Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function.
The role of endogenously oxidized low density lipoprotein (oxLDL) in follicular steroidogenic regulation is unknown. Information may be important in order to elucidate ovulatory dysregulation in disordered lipid metabolism. To obtain specific data, we studied the effect of polar phospholipids (PL) isolated from oxLDL with different endogenous levels of lipohydroperoxides (LHP) on the thecal expression of mRNA encoding steroidogenic enzymes and cyclooxygenase 2 (COX-2), and on the thecal production of superoxide and progesterone. Large (preovulatory) bovine follicles were used and analyses of thecal fragments from single follicles were performed by radioimmunoassays, chemiluminescence assays and quantitative RT-PCR. Basal concentration of mRNA for several lipoprotein receptors exceeded by about 10-times the basal level of mRNA encoding steroidogenic enzymes, suggesting that preovulatory theca receptors may favour uptake of oxLDL. PL (5-11 pmol phosphorus/ml) decreased (up to 0.5-times the control) progesterone synthesis, production of superoxide and levels of P450 cholesterol side chain cleavage (P450 scc), 3beta-hydroxysteroid dehydrogenase and COX-2 mRNA. Abundance of COX-2 transcripts in thecal tissue incubated with forskolin depended on the progesterone/17beta-oestradiol ratio of the follicle fluid, i.e. the previous microenvironment in vivo. PL effects were mimicked by the platelet-activating factor (PAF). WEB 2086, a PAF receptor blocker, did not always abolish these responses, suggesting that the effects were not mediated solely by this receptor. PAF interfered dose-dependently with LH-induced responses, indicating interference with LH signalling. PL from mildly oxidized LDL (0.5 nmol/ml LHP) tended to exert greater effects than PL from oxLDL containing 1.5 nmol/ml LHP. In consideration of the known physiologic role of progesterone, COX-2 and possibly superoxide, these results provide evidence for a potential of PL from oxLDL to induce ovulatory dysregulation and suggest that the extent of the LDL oxidation seems to be important for interfering with thecal responses to the preovulatory LH surge.
Löhrke
B
B
Unit of Reproductive Biology, Research Institute for the Biology of Farm Animals, Dummerstorf, Germany.
Viergutz
T
T
Krüger
B
B
D015096:3-Hydroxysteroid Dehydrogenases / Q000235:genetics; D000818:Animals; D001483:Base Sequence; D002417:Cattle; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000235:genetics; D051546:Cyclooxygenase 2 / Q000235:genetics; D005260:Female; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008054:Lipid Peroxides / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000494:pharmacology; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D018110:Receptors, Lipoprotein / Q000235:genetics; D013481:Superoxides / Q000378:metabolism; D013799:Theca Cells / Q000187:drug effects / Q000378:metabolism*
D008054:Lipid Peroxides; D008077:Lipoproteins, LDL; D010743:Phospholipids; D010972:Platelet Activating Factor; D012333:RNA, Messenger; D018110:Receptors, Lipoprotein; C099252:oxidized low density lipoprotein; D013481:Superoxides; D011374:Progesterone; D007986:Luteinizing Hormone; D015096:3-Hydroxysteroid Dehydrogenases; D002786:Cholesterol Side-Chain Cleavage Enzyme; D051546:Cyclooxygenase 2